Research Grants

Stomach Cancer Research Information

Per cancer death, stomach cancer receives the least amount of federal funding of any cancer and there is very little research being conducted on stomach cancer for a variety of reasons, including a lack of funding and a limited number of doctors specializing in stomach cancer. DDF strives to increase the treatment options available for stomach cancer patients by directly funding stomach cancer research.

By offering grants for basic, translational and clinical research in stomach cancer to scientists and clinicians at various career levels, Debbie's Dream Foundation: Curing Stomach Cancer is in the fight against the disease by advancing the field to make progress toward the goal of increasing survival.

Since 2014, Debbie's Dream Foundation has awarded $1,450,000 in research grants to help find a cure for stomach cancer. More information on grant opportunities and our past recipients can be found below.

 

image_gallery

Since 2014, Debbie's Dream Foundation: Curing Stomach Cancer and the American Association for Cancer Research have partnered to award/allocate research grants totaling $1,450,000 in funding to talented, motivated scientists across the country.

Learn how we’ve made an impact over the years. 

$
TOTAL IN FUNDING
See our impact...
Screenshot 2022-09-23 151736
Screenshot 2022-09-23 151620

2022

In 2022, Debbie’s Dream Foundation announced a $250,000 commitment to research grants. We partnered with
Stupid Strong to provide a $50,000 grant to help fund research at MD Anderson Cancer Center.

Read our press release here.

 

Meet Our 2022 Recipient

Moritz Eissmann, PhD

$200,000 2022 AACR-Debbie’s Dream Foundation Career Development
Award in Gastric Cancer Research

Olivia Newton-John
Cancer Research Institute

Funded Project: Identification of therapeutic
vulnerabilities that promote clonal fitness and
metastatic spread of gastric cancer cells in vivo

 


2021

In 2021, Debbie's Dream Foundation partnered with American Association for Cancer
Research to announce a $200,000 research grant for stomach cancer.

Read our press release here.


Meet Our Research Grant Recipients

Get to know the wonderful researchers who have benefitted from our research grants!

2019

In 2019, Debbie's Dream Foundation awarded $150,000 in research grants as follows:

Youn-Sang Jung, Ph.D. - Headshot
Ankur Nagaraja, MD, PhD. Photo by Sam Ogden.
Katsumi Yamaguchi, PhD - Headshot

Youn-Sang Jung, PhD

$50,000 Young Research Fellowship Grant

University of Texas MD Anderson Cancer Center
CRAD, a cytoskeletal tumor suppressor, in diffuse-type gastric cancer

Ankur Nagaraja, MD, PhD

$50,000 Young Research Fellowship Grant

Dana-Farber Cancer Institute
Replication stress as a therapeutic vulnerability in gastric cancer

Katsumi Yamaguchi, PhD

$50,000 Young Research Fellowship Grant

Johns Hopkins University-School of Medicine
The role of LINE-1 retrotransposition in gastric cancer


2018

In 2018, Debbie's Dream Foundation awarded $200,000 in research grants as follows:

Richard Hodge, PhD

Richard Hodge, PhD

$50,000 Young Research Fellowship Grant

The University of North Carolina at Chapel Hill
Aberrant RHOA function and signaling in driving diffuse gastric cancer

O'Brien,-Valerie-Headshot---Web

Valerie O'Brien, PhD

$50,000 Young Research Fellowship Grant

Fred Hutchinson Cancer Research Center
Assessing Helicobacter pylori contributions to stomach cancer progression

Poh,-Ashleigh-Headshot---Web

Ashleigh Poh, PhD

$50,000 Young Research Fellowship Grant

Olivia Newton-John Cancer Research Institute
Co-targeting HCK as a combination therapy to treat gastric cancer

Willet,-Spencer-headshot---Web

Spencer Willet, PhD

$50,000 Young Research Fellowship Grant

Washington University in St. Louis
The role of the Hippo pathway in gastric tumorigenesis


2017
In 2017, Debbie's Dream Foundation awarded $300,000 in research grants as follows:

image_gallery

Eunyoung Choi, PhD

$200,000 Career Development Award

Vanderbilt University Medical Center
A novel metaplastic organoid system for studying gastric carcinogenesis

image_gallery

Karolina Kaczor-Urbanowicz, PhD, DMD

$50,000 Young Research Fellowship Grant

University of California, Los Angeles
Salivary H. pylori exRNAs as biomarkers for gastric cancer detection

image_gallery

Haisheng Zhang, PhD

$50,000 Young Research Fellowship Grant

Dana-Farber Cancer Institute
RHOA alterations in the development of diffuse gastric cancer


2016
In 2016, Debbie's Dream Foundation awarded $200,000 in research grants as follows:

image_gallery

Elise S. Demitrack, PhD

$150,000 Career Development Research Grant Award

The Regents of the University of Michigan
Mechanisms of Wnt activation in FAP gastric polyps and gastric cancer

image_gallery

Holly A. Martinson, PhD

$50,000 Young Fellowship Research Grant Award

University of Alaska Anchorage
Discovering biomarkers for early detection and treatment of gastric cancer

2016 DoD $50 Million Peer Reviewed Cancer Research Program

Debbie's Dream Foundation successfully advocated to maintain stomach cancer's inclusion in the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). The PRCRP total budget for fiscal year 2016 is $50 million. FY16 PRCRP Program Announcements and General Application instructions can be found below and at this link: http://cdmrpweb-ua.srahosting.com/funding/prcrp.shtml.


2015
In 2015, Debbie's Dream Foundation awarded $100,000 in research grants as follows:

image_gallery

Eirini Pectasides, MD, PhD

$50,000 Young Fellowship Research Grant

Dana-Farber Cancer Institute
Enhancing the efficacy of ERBB2 inhibition in gastric cancer.

image_gallery

Andrea Zamperone, PhD

$50,000 Young Fellowship Research Grant

Albert Einstein College of Medicine of Yeshiva University
Mechanisms of DNA damage signaling by Helicobacter pylori


2014 Young Fellowship Research Grant
In 2014, Debbie's Dream Foundation awarded $50,000 in research grants as follows:

image_gallery

David Allison

$50,000 Young Fellowship Research Grant

University of North Carolina – Chapel Hill
To detail the regulatory mechanisms of a key epigenetic factor, the Enhancer of Zeste Homolog 2 (EZH2) with the hope to establish EZH2 and related cofactors as emerging targets for chemotherapeutics in gastric cancer